NCT03213314View on ClinicalTrials.gov

HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies

NACompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

September 7, 2017

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions
Liver CancerSurgeryLiver RegenerationColorectal Cancer Metastatic
Interventions
DIAGNOSTIC_TEST

Multiparameter magnetic resonance imaging

LiverMultiScan before and after surgery to assess liver health prior to liver resection and in the regenerative phase.

Trial Locations (2)

Unknown

Hampshire Hospitals Foundation Trust, Basingstoke

NHS Lothian Royal Infirmary of Edinburgh, Edinburgh

All Listed Sponsors
collaborator

Hampshire Hospitals NHS Foundation Trust

OTHER

collaborator

Perspectum

INDUSTRY

lead

University of Edinburgh

OTHER

NCT03213314 - HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies | Biotech Hunter | Biotech Hunter